DSGN FY 2023 Earnings — Design Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DSGNDesign Therapeutics, Inc.

$569M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$537,000

Operating Income

-$78M

Net Income

-$67M

EPS (Diluted)

$-1.19

Cash Flow

Operating Cash Flow

-$59M

Free Cash Flow

-$59M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$290M

Total Liabilities

$12M

Stockholders' Equity

$278M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$537,000	-$466,000	-15.2%
Operating Income	-$78M	-$68M	-15.7%
Net Income	-$67M	-$63M	-5.6%